Join Now

Category Archives: BioUtah News

Representative McAdams Honored with the 2020 Champion of Health Care Innovation Award

By Denise Bell | Published December 4, 2020

In a virtual December 3 ceremony, the American Life Sciences Innovation Council (ALSIC), BioUtah and several state and local-based patient organizations, presented Rep. Ben McAdams (UT-4) with the 2020 Champion of Health Care Innovation Award. The award recognizes McAdams for his work in Congress to protect and nurture the important policies that position Utah and […]

Also posted in Policy News | | Leave a comment

Utah Life Sciences Leaders Honored At 2020 Virtual Life Sciences Summit

By Denise Bell | Published November 13, 2020

On the last day of the Summit, BioUtah announced its 2020 Utah Life Sciences award winners, which were presented during a special virtual awards session. Gary Crocker, president of Crocker Ventures, was honored with a Lifetime Achievement Award Other distinguished award winners include Salt Lake City Mayor Erin Mendenhall; Chris Gibson, CEO, Recursion Pharmaceuticals; Randy Rasmussen, co-founder, […]

Also posted in Feature, State News, Utah's Life Sciences Companies | | Leave a comment

Quansys Biosciences Receives EUA for COVID-19 Antibody Test, Provides Exceptional Clinical Performance

By Denise Bell | Published November 13, 2020

Quansys Biosciences has received  emergency use authorization (EUA) from the FDA for its COVID-19 antibody test. The test allows simultaneous detection of human antibodies to the SARS-CoV-2 S1 protein and the SARS-CoV-2 S2 protein, which has shown measurable improvement in clinical performance, compared to tests using a single protein. “This is very welcome news, said […]

Also posted in Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

SDP Oncology Announces First Patient Dosed in a Phase 1 Solid Tumor Study

By Denise Bell | Published November 13, 2020

Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently announced that the first patient has been dosed with the PKM2 activator, TP-1454, in a Phase 1/1b study in patients with advanced metastatic or progressive solid tumors.  “Dosing the first patient in this study marks an important milestone, as TP-1454 is the first PKM2 activator to be […]

Also posted in Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

BioHive Launched at Utah Life Sciences Summit – Join the Campaign 

By Denise Bell | Published November 13, 2020

  The 11th annual Utah Life Sciences Summit (ULSS) Nov. 9-11, went virtual this year. But despite the physical distance, the ULSS made news and ignited our life sciences industry with a special announcement — the launch of BioHive, a new bold campaign to brand and expand Utah’s life sciences ecosystem. ICYMI…view the video and see […]

Also posted in Economic Developments, Life Sciences Industry News, State News, Utah's Life Sciences Companies | | Leave a comment

Transit Scientifc’s New Angioplasty System Dilates Calcified & Fibrotic Vessels

By admin | Published November 12, 2020

Transit Scientific’s new FDA cleared XO Score system was successfully used to dilate multiple challenging fibrotic and calcific lesions in hemodialysis patients with stenotic and occluded fistulas. Dr. Richard Saxon, FSIR and member of the SDI Medical Group, while working at  Tri City Medical Center Medical Center,  Oceanside, California, USA performed the first procedures using […]

Also posted in Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

Dr. Dinesh C. Patel Honored with Utah Governor’s Lifetime Achievement Medal

By Denise Bell | Published October 30, 2020

Utah’s own life sciences entrepreneur, Dinesh C. Patel, PhD, has been honored with the Utah Governor’s Lifetime Achievement Medal for Science and Technology for his contribution in the field of biotechnology and pharmaceuticals. “This honor is well-deserved,” said Kelvyn Cullimore, president and CEO of BioUtah. “Dr. Patel has been instrumental in founding and bringing a […]

Also posted in Industry News, Life Sciences Industry News, State News, Utah's Life Sciences Companies | | Leave a comment

IDbyDNA and Illumina Launch New Rapid Test to Better Detect COVID-19, Flu, Respiratory Co-Infections

By Denise Bell | Published October 16, 2020

Utah-based IDbyDNA announced yesterday that, in an effort to help labs better identify respiratory pathogens and avoid overuse of antimicrobial drugs, IDbyDNA and Illumina, Inc. are co-launching the new Respiratory Pathogen ID/AMR Target Enrichment Assay. The test, currently for research use only, will improve testing for infectious diseases, including COVID-19, and will leverage IDbyDNA’s Explify® […]

Also posted in COVID-19 Updates, Life Sciences Industry News, Press Releases, State News, Utah's Life Sciences Companies | | Leave a comment

SDP Oncology Announces First Patient Dosed in a Phase 1 Solid Tumor Study

By Denise Bell | Published October 16, 2020

Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently announced that the first patient has been dosed with the PKM2 activator, TP-1454, in a Phase 1/1b study in patients with advanced metastatic or progressive solid tumors.  “Dosing the first patient in this study marks an important milestone, as TP-1454 is the first PKM2 activator to be […]

Also posted in Featured Members, Life Sciences Industry News, State News, Utah's Life Sciences Companies | | Leave a comment

Governor Herbert Announces New COVID-19 Transmission Index

By Denise Bell | Published October 16, 2020

On Wednesday, Governor Herbert announced the state’s new response plan to COVID-19, effective October 15. This updated plan utilizes a COVID-19 Transmission Index and replaces the previous color-coded guidance system of red, orange, yellow and green. The new approach comes at a time when the state has seen a significant spike in infection rates. The […]

Also posted in Business Tools & Resources, COVID-19 Updates, State News, Utah's Life Sciences Companies | | Leave a comment

Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed with TP-1454 in Patients with Advanced Solid Tumors 

By Denise Bell | Published October 14, 2020

CAMBRIDGE, Mass., October 9, 2020 – Sumitomo Dainippon Pharma Oncology, Inc., a developer of novel cancer therapeutics, today announced that the first patient has been dosed with TP-1454, an investigational small-molecule pyruvate kinase M2 isoform (PKM2) activator, administered alone and in combination with ipilimumab and nivolumab, in a Phase 1/1b study in patients with advanced […]

Also posted in Industry News, Life Sciences Industry News | | Leave a comment

SINTX Technologies Develops New Mask Fabric with Silicon Nitride

By Denise Bell | Published October 9, 2020

On Tuesday, SINTX Technologies (SINTX) announced progress toward the manufacture of a “catch-and-kill” mask that will inactivate respiratory viruses. SINTX has successfully embedded silicon nitride particles into nonwoven and woven fabric fibers. Silicon nitride has been shown to neutralize several bacterial species and viral strains, including SARS-CoV-2.  “By investing in our human resources and equipment, […]

Also posted in State News, Utah's Life Sciences Companies | | Leave a comment

A Special Thanks To Our Legacy and Platinum Elite Members